Gene-gene and gene-environment interactions in mild hyperhomocysteinemia

Armando D'Angelo, Giuseppina Mazzola, Isabella Fermo

Research output: Contribution to journalArticle

Abstract

Mild/moderate hyperhomocysteinemia (HHcy), a highly prevalent condition, is independently associated with an increased risk of arterial and venous thromboembolic diseases. Early reports of the association of mild/moderate HHcy with juvenile venous thromboembolism have shown familiarity for HHcy in relatives of index cases with thrombosis. Similar to inherited thrombophilia defects, inheritance of the HHcy phenotype was accordingly retained important for the definition of HHcy as an independent risk factor for thrombosis. A number of common polymorphisms in genes coding for methylenetetrahydrofolate reductase (MTHFR), methionine-synthase, methionine-synthase reductase and cysthationine β-synthase (CBS) have been explored for their association with homocysteine levels, fasting and post-methionine load, and with thrombotic diseases. MTHFR thermolability accounts for a 10-fold increase in the risk of mild/moderate HHcy. With the possible exception of the CBS 844ins68 insertion, there is no evidence for an increased risk of HHcy for any of these polymorphisms, isolated or in association with MTHFR thermolability. Environmental factors and MTHFR thermolability are main determinants of the HHcy phenotype. If mild/moderate HHcy is a pathogenetic risk factor for thrombosis, intervention aimed to improve the vitamin status appears of major importance, irrespective of common gene polymorphisms of the homocysteine metabolism.

Original languageEnglish
Pages (from-to)337-341
Number of pages5
JournalPathophysiology of Haemostasis and Thrombosis
Volume33
Issue number5-6
DOIs
Publication statusPublished - 2003

Fingerprint

Gene-Environment Interaction
Hyperhomocysteinemia
Methylenetetrahydrofolate Reductase (NADPH2)
Genes
Thrombosis
Homocysteine
5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase
Phenotype
Thrombophilia
Venous Thromboembolism
Vitamins
Methionine
Fasting

Keywords

  • Cysthationine synthase
  • Hyperhomocysteinemia
  • Methionine-synthase
  • Methionine-synthase reductase
  • Methylenetetrahydrofolate reductase
  • Polymorphisms
  • Thrombosis
  • Transcobalamin

ASJC Scopus subject areas

  • Hematology

Cite this

Gene-gene and gene-environment interactions in mild hyperhomocysteinemia. / D'Angelo, Armando; Mazzola, Giuseppina; Fermo, Isabella.

In: Pathophysiology of Haemostasis and Thrombosis, Vol. 33, No. 5-6, 2003, p. 337-341.

Research output: Contribution to journalArticle

@article{49ebc703335646fd87225250cb67e252,
title = "Gene-gene and gene-environment interactions in mild hyperhomocysteinemia",
abstract = "Mild/moderate hyperhomocysteinemia (HHcy), a highly prevalent condition, is independently associated with an increased risk of arterial and venous thromboembolic diseases. Early reports of the association of mild/moderate HHcy with juvenile venous thromboembolism have shown familiarity for HHcy in relatives of index cases with thrombosis. Similar to inherited thrombophilia defects, inheritance of the HHcy phenotype was accordingly retained important for the definition of HHcy as an independent risk factor for thrombosis. A number of common polymorphisms in genes coding for methylenetetrahydrofolate reductase (MTHFR), methionine-synthase, methionine-synthase reductase and cysthationine β-synthase (CBS) have been explored for their association with homocysteine levels, fasting and post-methionine load, and with thrombotic diseases. MTHFR thermolability accounts for a 10-fold increase in the risk of mild/moderate HHcy. With the possible exception of the CBS 844ins68 insertion, there is no evidence for an increased risk of HHcy for any of these polymorphisms, isolated or in association with MTHFR thermolability. Environmental factors and MTHFR thermolability are main determinants of the HHcy phenotype. If mild/moderate HHcy is a pathogenetic risk factor for thrombosis, intervention aimed to improve the vitamin status appears of major importance, irrespective of common gene polymorphisms of the homocysteine metabolism.",
keywords = "Cysthationine synthase, Hyperhomocysteinemia, Methionine-synthase, Methionine-synthase reductase, Methylenetetrahydrofolate reductase, Polymorphisms, Thrombosis, Transcobalamin",
author = "Armando D'Angelo and Giuseppina Mazzola and Isabella Fermo",
year = "2003",
doi = "10.1159/000083824",
language = "English",
volume = "33",
pages = "337--341",
journal = "Pathophysiology of Haemostasis and Thrombosis",
issn = "1424-8832",
publisher = "S. Karger AG",
number = "5-6",

}

TY - JOUR

T1 - Gene-gene and gene-environment interactions in mild hyperhomocysteinemia

AU - D'Angelo, Armando

AU - Mazzola, Giuseppina

AU - Fermo, Isabella

PY - 2003

Y1 - 2003

N2 - Mild/moderate hyperhomocysteinemia (HHcy), a highly prevalent condition, is independently associated with an increased risk of arterial and venous thromboembolic diseases. Early reports of the association of mild/moderate HHcy with juvenile venous thromboembolism have shown familiarity for HHcy in relatives of index cases with thrombosis. Similar to inherited thrombophilia defects, inheritance of the HHcy phenotype was accordingly retained important for the definition of HHcy as an independent risk factor for thrombosis. A number of common polymorphisms in genes coding for methylenetetrahydrofolate reductase (MTHFR), methionine-synthase, methionine-synthase reductase and cysthationine β-synthase (CBS) have been explored for their association with homocysteine levels, fasting and post-methionine load, and with thrombotic diseases. MTHFR thermolability accounts for a 10-fold increase in the risk of mild/moderate HHcy. With the possible exception of the CBS 844ins68 insertion, there is no evidence for an increased risk of HHcy for any of these polymorphisms, isolated or in association with MTHFR thermolability. Environmental factors and MTHFR thermolability are main determinants of the HHcy phenotype. If mild/moderate HHcy is a pathogenetic risk factor for thrombosis, intervention aimed to improve the vitamin status appears of major importance, irrespective of common gene polymorphisms of the homocysteine metabolism.

AB - Mild/moderate hyperhomocysteinemia (HHcy), a highly prevalent condition, is independently associated with an increased risk of arterial and venous thromboembolic diseases. Early reports of the association of mild/moderate HHcy with juvenile venous thromboembolism have shown familiarity for HHcy in relatives of index cases with thrombosis. Similar to inherited thrombophilia defects, inheritance of the HHcy phenotype was accordingly retained important for the definition of HHcy as an independent risk factor for thrombosis. A number of common polymorphisms in genes coding for methylenetetrahydrofolate reductase (MTHFR), methionine-synthase, methionine-synthase reductase and cysthationine β-synthase (CBS) have been explored for their association with homocysteine levels, fasting and post-methionine load, and with thrombotic diseases. MTHFR thermolability accounts for a 10-fold increase in the risk of mild/moderate HHcy. With the possible exception of the CBS 844ins68 insertion, there is no evidence for an increased risk of HHcy for any of these polymorphisms, isolated or in association with MTHFR thermolability. Environmental factors and MTHFR thermolability are main determinants of the HHcy phenotype. If mild/moderate HHcy is a pathogenetic risk factor for thrombosis, intervention aimed to improve the vitamin status appears of major importance, irrespective of common gene polymorphisms of the homocysteine metabolism.

KW - Cysthationine synthase

KW - Hyperhomocysteinemia

KW - Methionine-synthase

KW - Methionine-synthase reductase

KW - Methylenetetrahydrofolate reductase

KW - Polymorphisms

KW - Thrombosis

KW - Transcobalamin

UR - http://www.scopus.com/inward/record.url?scp=14044268047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14044268047&partnerID=8YFLogxK

U2 - 10.1159/000083824

DO - 10.1159/000083824

M3 - Article

C2 - 15692239

AN - SCOPUS:14044268047

VL - 33

SP - 337

EP - 341

JO - Pathophysiology of Haemostasis and Thrombosis

JF - Pathophysiology of Haemostasis and Thrombosis

SN - 1424-8832

IS - 5-6

ER -